Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

ClinicalTrials.gov ID: NCT03942601

Public ClinicalTrials.gov record NCT03942601. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03942601
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mercator MedSystems, Inc.
Industry
Enrollment
10 participants

Conditions and interventions

Interventions

  • Temsirolimus Drug
  • Temsirolimus and dexamethasone sodium phosphate Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2019
Primary completion
Apr 29, 2021
Completion
Apr 29, 2021
Last update posted
Jul 9, 2024

2019 – 2021

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Arkansas Heart Hospital Little Rock Arkansas 72211
St. Joseph Hospital of Orange Heart and Vascular Center Orange California 92868
San Francisco VA Medical Center San Francisco California 94121
University of Colorado Denver Colorado 80045
Rocky Mountain Veterans Administration Hospital Denver Colorado 80220
Advocate Christ Medical Center Oak Lawn Illinois 60453
Columbia University Medical Center/NYPH New York New York 10032
North Carolina Heart and Vascular Raleigh North Carolina 27607
University Hospital Cleveland Ohio 44106
Einstein Medical Center Philadelphia Pennsylvania 19141
Baylor College of Medicine Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03942601, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2024 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03942601 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →